Abstract
Aspiration of abdominal subcutaneous fat tissue is a safe, inexpensive, reliable, minimally invasive, and easy procedure with high diagnostic yield that can be done early after clinical suspicion of amyloidosis and can be repeated if required anytime during the course of the disease. Material obtained in this way is highly suitable for detection, typing, and quantification of amyloid and can also be used for chemical tissue analysis using proteomic techniques. The procedure has great potential to enable dynamic research of local tissue factors involved both in deposition and removal of amyloid in vivo. In the Appendix of this chapter, we describe the current practice of this procedure in our center.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Schilder P. Über die amyloide Entartung der Haut. Frankfurt Z Pathol. 1909;3:782–94.
Westermark P, Stenkvist B. Diagnosis of secondary generalized amyloidosis by fine needle biopsy of the skin. Acta Med Scand. 1971;190:453–4.
Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522–3.
Westermark P, Stenkvist B, Natvig JB, et al. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis. 1979;38:68–71.
Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med. 1983;143:1549–52.
Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol. 1989;7:407–10.
Westermark P. Diagnosis and characterization of systemic amyloidosis by biopsy of subcutaneous abdominal fat tissue. Intern Med Specialist. 1984;5:154–60.
Olsen KE, Sletten K, Westermark P. The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay. Am J Clin Pathol. 1999;111:355–62.
Westermark P. Subcutaneous adipose tissue biopsy for amyloid protein studies. Methods Mol Biol. 2012;849:363–71.
Hazenberg BP, Limburg PC, Bijzet J, van Rijswijk MH. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis. Ann Rheum Dis. 1999;58:96–102.
Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10:355–63.
Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134:545–51.
Giorgadze TA, Shiina N, Baloch ZW, Tomaszewski JE, Gupta PK. Improved detection of amyloid in fat pad aspiration: an evaluation of Congo red stain by fluorescent microscopy. Diagn Cytopathol. 2004;31:300–6.
Ishii W, Matsuda M, Nakamura N, et al. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:400–5.
Ponce P, Carvalho F, Coelho A. Valeur de la ponction-aspiration de la graisse sous-cutanée dans le diagnostic de l’amylose. Nephrologie. 1986;7:25–7.
Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol. 1987;16:429–31.
Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929–33.
Sorsa S, Happonen RP, Klemi P. Oral biopsy and fine needle aspiration biopsy from subcutaneous fat in diagnosis of secondary amyloidosis. Int J Oral Maxillofac Surg. 1988;17:14–6.
Duston MA, Skinner M, Meenan RF, Cohen AS. Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum. 1989;32:82–5.
Dupond JL, de Wazières B, Saile R, et al. L’amylose systémique du sujet âgé: valeur diagnostique de l’examen de la graisse sous-cutanée abdominale et des glandes salivaires accessoires. Étude prospective chez 100 patients âgés. Rev Med Interne. 1995;16:314–7.
Masouye I. Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: an analysis of 100 cases. Am J Dermatopathol. 1997;19:41–5.
Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. Diagn Cytopathol. 2001;24:181–5.
Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol. 2004;30:178–81.
van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015–21.
Dhingra S, Krishnani N, Kumari N, Pandey R. Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis. Acta Cytol. 2007;51:860–4.
Blumenfeld W, Hildebrandt RH. Fine needle aspiration of abdominal fat for the diagnosis of amyloidosis. Acta Cytol. 1993;37:170–4.
Lipschutz JH, Miller T, Yen TS, Vartanian RK, Graber ML, Damon L. Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol. 1995;15:431–5.
Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA. Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy. Mayo Clin Proc. 2002;77:1287–90.
Päi S, Helin H, Isomäki H. Frequency of amyloidosis in Estonian patients with rheumatoid arthritis. Scand J Rheumatol. 1993;22:248–9.
Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomäki H. Amyloidosis–incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol. 1993;22:158–61.
Gratacos J, Orellana C, Sanmarti R, et al. Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol. 1997;24:912–5.
El Mansoury TM, Hazenberg BP, El Badawy SA, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42–7.
Ishii W, Matsuda M, Nakamura A, Nakamura N, Suzuki A, Ikeda S. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med. 2003;42:800–5.
Alishiri GH, Salimzadeh A, Owlia MB, Forghanizadeh J, Setarehshenas R, Shayanfar N. Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics. BMC Musculoskelet Disord. 2006;7:43.
Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R. Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol. 2007;34:371–3.
Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol. 2003;30:948–51.
Wiland P, Wojtala R, Goodacre J, Szechinski J. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis. Clin Rheumatol. 2004;23:193–8.
Fine NM, Arruda-Olson AM, Dispenzieri A, et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014;113:1723–7.
Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid. 2011;18:211–5.
Takashio S, Izumiya Y, Jinnin M, et al. Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis. Am J Cardiol. 2012;110:1507–11.
Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012;19:167–70.
Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid. 2002;9:108–14.
Hazenberg AJ, Dikkers FG, Hawkins PN, et al. Laryngeal presentation of systemic AApoAI amyloidosis in patients with apolipoprotein AI variants Leu174Ser and Leu178Pro. Laryngoscope. 2009;119:608–15.
Varga J, Idelson BA, Felson D, Skinner M, Cohen AS. Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med. 1987;147:1455–7.
Orfila C, Goffinet F, Goudable C, et al. Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients. Am J Nephrol. 1988;8:454–6.
Solé Arqués M, Campistol JM, Muñoz-Gómez J. Abdominal fat aspiration biopsy in dialysis-related amyloidosis. Arch Intern Med. 1988;148:988.
Sethi D, Cary NR, Brown EA, Woodrow DF, Gower PE. Dialysis-associated amyloid: systemic or local? Nephrol Dial Transplant. 1989;4:1054–9.
Uemichi T, Liepnieks JJ, Gertz MA, Benson MD. Fibrinogen A alpha chain Leu 554: an African-American kindred with late onset renal amyloidosis. Amyloid. 1998;5:188–92.
Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108:209–13.
Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5:55–66.
Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kurtin PJ, Grogg KL, Dogan A. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based. Haematologica. 2014;99:1239–47.
Sie MP, van der Wiel HE, Smedts FM, de Boer AC. Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med. 2010;68:138–40.
Shikama Y, Kitazawa J, Yagihashi N, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med. 2010;49:397–401.
D’Souza A, Theis JD, Vrana JA, Buadi F, Dispenzieri A, Dogan A. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate. Am J Hematol. 2012;87:E131–2.
Orfila C, Giraud P, Modesto A, Suc JM. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol. 1986;17:366–9.
Halloush RA, Lavrovskaya E, Mody DR, Lager D, Truong L. Diagnosis and typing of systemic amyloidosis: the role of abdominal fat pad fine needle aspiration biopsy. Cytojournal. 2010;6:24.
Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008;216:253–61.
Kaplan B, Vidal R, Kumar A, Ghiso J, Gallo G. Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat. Am J Clin Pathol. 1999;112:403–7.
De Larrea CF, Verga L, Morbini P, et al. Immuno-electron microscopy in the classification of systemic amyloidosis: experience in 423 patients from a single institution. XIVth International symposium on amyloidosis 2014 “Amyloid: Insoluble, but solvable”. Indianapolis, 2014; Abstract OP-15, p. 32–3.
Fernández de Larrea C, Verga L, Morbini P, et al. A practical approach to the diagnosis of systemic amyloidoses. Blood. 2015;125:2239–44.
Hazenberg BP, Bijzet J, Limburg PC, et al. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid. 2007;14:133–40.
Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheumatol. 1988;6:395–7.
Sjöholm K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab. 2005;90:2233–9.
Bijzet J, de Boer L, Haagsma EB, Hazenberg BP. An indirect ELISA for transthyretin quantification in fat tissue of patients with ATTR amyloidosis. In: Hazenberg BP, Bijzet J, editors. XIIIth International symposium on amyloidosis 2012 “From misfolded proteins to well-designed treatment”. Groningen: GUARD; 2013. p. 168–70.
Bijzet J, van Gameren II, Limburg PC, Bos R, Vellenga E, Hazenberg BP. Diagnostic performance of measuring free light chains in fat tissue of patients with AL amyloidosis. Amyloid. 2011;18 Suppl 1:71–2.
Picken MM, Herrera GA. The burden of “sticky” amyloid: typing challenges. Arch Pathol Lab Med. 2007;131:850–1.
Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16:196–203.
Pras M, Schubert M, Zucker-Franklin D, et al. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968;47:924–33.
Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885–90.
Westermark P, Benson L, Juul J, Sletten K. Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis. J Clin Pathol. 1989;42:817–9.
Forsberg AH, Sletten K, Benson L, et al. Abdominal fat biopsy for characterization of the major amyloid fibril proteins by amino acid sequence. In: Natvig JB, Forre O, Husby G, editors. Amyloid and amyloidosis 1990. Norwell, MA: Kluver Academic; 1990. p. 797–800.
Olsen KE, Sletten K, Westermark P. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998;245:713–6.
Kaplan B, Hrncic R, Murphy CL, Gallo G, Weiss DT, Solomon A. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol. 1999;309:67–81.
Kaplan B, Murphy CL, Ratner V, Pras M, Weiss DT, Solomon A. Micro-method to isolate and purify amyloid proteins for chemical characterization. Amyloid. 2001;8:22–9.
Kaplan B, Shtrasburg S, Pras M. Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol. 2003;56:86–90.
Murphy CL, Eulitz M, Hrncic R, et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol. 2001;116:135–42.
Kaplan B, Martin BM, Livneh A, Pras M, Gallo GR. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol. 2004;121:794–800.
Murphy CL, Wang S, Williams T, Weiss DT, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412:48–62.
Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen 3rd HR, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957–9.
Lavatelli F, Perlman DH, Spencer B, et al. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics. 2008;7:1570–83.
Brambilla F, Lavatelli F, Di Silvestre D, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 2012;119:1844–7.
Brambilla F, Lavatelli F, Di Silvestre D, et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 2013;12:5642–55.
Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid. 2011;18:177–82.
Westermark P. Amyloid diagnosis, subcutaneous adipose tissue, immunohistochemistry and mass spectrometry. Amyloid. 2011;18:175–6.
Kimmich C, Hegenbart U, Schönland SO, Bijzet J, Hazenberg BP. Introduction of fat aspiration at a tertiary institution to diagnose systemic amyloidosis. In: Benson MD, Kluve-Beckerman B, Liepnieks JJ, editors. XIVth International symposium on amyloidosis 2014 “Amyloid: Insoluble, but solvable”. Indianapolis; 2014.
Gómez-Casanovas E, Sanmartí R, Solé M, Cañete JD, Muñoz-Gómez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66–72.
Bardarov S, Michael CW, Pu RT, Pang Y. Computer-assisted image analysis of amyloid deposits in abdominal fat pad aspiration biopsies. Diagn Cytopathol. 2009;37:30–5.
van Gameren II, Hazenberg BP, Bijzet J, et al. Amyloid load in fat tissue in patients with amyloidosis reflects disease severity and predicts survival. Arthritis Care Res (Hoboken). 2010;62:296–301.
Haagsma EB, van Gameren II, Bijzet J, Posthumus MD, Hazenberg BP. Familial amyloidotic polyneuropathy: long-term follow-up of abdominal fat tissue aspirate in patients with and without liver transplantation. Amyloid. 2007;14:221–6.
Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl. 2008;14:563–70.
Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol. 2011;42:236–43.
Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med. 2011;89:171–80.
Ihse E, Rapezzi C, Merlini G, et al. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid. 2013;20:142–50.
van Gameren II, van Rijswijk MH, Bijzet J, Vellenga E, Hazenberg BP. Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica. 2009;94:1094–100.
Nilsson KP, Ikenberg K, Åslund A, et al. Structural typing of systemic amyloidosis by luminescent-conjugated polymer spectroscopy. Am J Pathol. 2010;176:563–74.
Sjölander D, Bijzet J, Hazenberg BP, Nilsson KP, Hammarström P. Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue. Amyloid. 2015;22(1):19–25.
Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyten and regulation by obesity and nutrition. Diabetologia. 2005;48:519–28.
Upragarin N, Landman WJ, Gaastra W, Gruys E. Extrahepatic production of acute phase serum amyloid A. Histol Histopathol. 2005;20:1295–307.
Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol. 1999;155:123–33.
Elimova E, Kisilevsky R, Szarek WA, Ancsin JB. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J. 2004;18:1749–51.
Magy N, Benson MD, Liepnieks JJ, Kluve-Beckerman B. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid. 2007;14:51–63.
Ishii W, Liepnieks JJ, Yamada T, Benson MD, Kluve-Beckerman B. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium. Amyloid. 2013;20:61–71.
Fat aspiration procedure for the detection of amyloid—instruction video. http://www.amyloid.nl/investigations.htm. Accessed 14 July 2014.
Kettwich LG, Sibbitt Jr WL, Emil NS, et al. New device technologies for subcutaneous fat biopsy. Amyloid. 2012;19:66–73.
Devata S, Hari P, Markelova N, Li R, Komorowski R, Shidham VB. Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: role of electron microscopy and Congo red stained cell block sections. Cytojournal. 2011;8:11.
Shidham VB, Hunt B, Jardeh SS, Barboi AC, Devata S, Hari P. Performing and processing FNA of anterior fat pad for amyloid. J Vis Exp. 2010;30(44). pii: 1747.
Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. J Nucl Med. 1998;39:699–706.
Commercial kit for SAA ELISA. http://www.hycultbiotech.com/products/innate-immunity/acute-phase-proteins/acute-phase-proteins-saa-human-elisa-kit-p11209-html. Accessed 14 July 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix: Fat Aspiration Technique and Tissue Analysis Currently Practiced in Groningen
Fat Aspiration Technique
Stepwise Description of the Procedure
Aspiration of abdominal subcutaneous fat tissue is a simple outpatient procedure and a modification of the procedure was described by Gertz [17]. It should be noted that it takes at least 10–15 min to avoid unnecessary pain and bruising and to get adequate material. The patient should be told that bruising might occur. For a description and instruction video of the fat aspiration procedure one can visit our website www.amyloid.nl [103]. Alternative procedures have been described, such as by Kettwich et al. [104] and also for preparing and performing electron microscopy on fat tissue [105, 106].
See Table 16.3 for the equipment we use. A syringe of 10 ml is connected by a valve system to a 16-gauge needle (Fig. 16.5a). After closing the valve, the plunger is pulled out, fixed transiently between squeezed thumb and finger, the cap of the lidocaine needle is reused elegantly by positioning it upside-down inside the plunger (Tarek’s trick) to fix firmly and definitely the position of the plunger, and thus maintaining negative pressure in the syringe during aspiration (Fig. 16.5b). The skin of the patient is marked and cleansed (e.g., with chloorhexidine) at both sides of the umbilicus at about 7–10 cm distance. Check first that the patient is not allergic to lidocaine. Skin and subcutaneous tissue (three directions, see below) are then anesthetized with lidocaine (each side 2 ml = 20 mg).
After inserting the needle beneath the skin, the valve is opened to start aspiration of fat tissue (Fig. 16.6a). The needle can be moved into three directions (Northeast, East, and Southeast) at the left side of the abdomen and mirror-wise at the right side. The aspiration procedure should be performed slowly and gently into each of the three directions, going to and fro with some axial rotation, and one should realize that it will take some time before the needle will be filled with fat tissue and the first fat can be seen passing the valve and entering the top of the syringe. This should be continued at both sides of the umbilicus until at least 60 mg of fat tissue has been collected (Fig. 16.6b). After the procedure has been finished, the puncture site should be covered with a band aid and pressed for a while to prevent substantial bruising.
The next step may be as simple as this: Seal the syringe, keep it cool (4 °C) until shipment, and send it at room temperature to a diagnostic center (e.g., UMC Groningen) for analysis as soon as possible, but at the latest arriving there within 1 week after the procedure.
Frequently Encountered Problems During the Procedure
Two technical problems can be encountered during aspiration: no tissue at all or too much blood entering the syringe.
If no fat appears in the syringe or the aspiration has stopped completely for some time, the needle may have become obstructed. The simplest way to check this is to pull the needle out of the patient. Normally, fat tissue present in the needle is then directly and audibly forced into the syringe because of negative pressure. If this is not the case and fat tissue obstructs the needle completely, tissue in the needle can be removed by using positive pressure in the syringe. This may result in a rather explosive evacuation (firing fat tissue) and should therefore be carried out carefully. The needle is introduced into a clean container (e.g., sputum or urine) or empty syringe: tissue is then evacuated into this container or syringe, while fixing the needle firmly to the syringe to prevent the needle leaving the syringe (firing needles).
If much arterial or venous blood enters the syringe by accident, the needle should be removed out of the body. The puncture site should be pressed for at least 1 min, and the procedure can be repeated into a different direction or at a different site. Pain is infrequent, localized, and seldom a real problem necessitating the use of more lidocaine. If bruising is suspected to be present at the end of the procedure, the patient him/herself may press the puncture site for a couple of minutes before rising from the supine position. At the end of the procedure, after sealing the two syringes, both puncture sites should be inspected for the development of significant bruising. If these safety precautions are taken routinely, the chance of severe bleeding or infections is very small. In about 2,000 procedures in our hospital, we observed twice a bleeding complication necessitating surgical assistance to find and stop the bleeding locus and once a local infection of the abdominal wall necessitating surgical drainage after incision combined with antibiotic treatment.
Congo Red Stain and Grading of Amyloid in Fat Tissue
Preparing Slides for Microscopy
After extracting the plunger, fat tissue can be collected from the syringe on an empty glass slide to separate fat tissue from accidentally obtained blood. At least four visible fragments of fat tissue (not fat droplets!) should be put on each of three glass slides (preferably with a frosted edge, which can be used to write on it with a pencil). These fragments are crushed into a single layer by squeezing a second slide placed perpendicularly to the first ones (Fig. 16.7a, b). It is important to press in the middle of the glass slides to prevent breaking of glass. The resulting six smears are marked for identification, dried in the air at room temperature for 1 h, and subsequently fixed with acetone for 10 min. After drying and fixation, all slides can be stored at room temperature until shipped to a reference laboratory for staining with Congo red and further study if positive for amyloid. Fat tissue should not be frozen before slides have been made: freezing of fresh and unfixed tissue may affect the quality of the tissue.
Congo Red Stain, Microscopy, and Amyloid Grading
Staining with alkaline Congo red should be performed according to the classic method described by Puchtler [11]. See Table 16.4 for a short summary. Commercial kits for Congo red stain are also available and have been used successfully, in particular in the US (MM Picken, personal communication).
The affinity of tissue for Congo red can be analyzed by the apple-green birefringence in polarized light using a good microscope. In our institution, we use the Olympus BX 50 microscope and a strong (100 W) light source. Two investigators score the slides blinded to the clinical data and in a semiquantitative grading system (Fig. 16.2): 0 (negative, no apple-green birefringence detectable), 1+ (minute, <1 % of surface area), 2+ (little, between 1 % and 10 %), 3+ (moderate, between 10 % and 60 %), 4+ (abundant, >60 %). Because some deposits may be tiny and hardly visible in daylight conditions, the slides, ideally, should be read in the dark. Kimmich et al. show nicely how this technique reliably can be introduced and successfully implemented in another center [85].
Immunochemical Quantification of Amyloid Proteins in Fat Tissue Extracts
Aim of the fat aspiration procedure is to obtain first an adequate quantity for microscopic analysis (3 × 4 lumps with total weight about 30 mg) and further at least 30 mg of fat tissue for immunochemical quantification of the amyloid proteins. After extracting the plunger, fat tissue is collected from the syringe on an empty glass slide to separate fat tissue from accidentally obtained blood and the 12 lumps of fat are used for the smears (vide supra). Before quantification, the amount of fat is weighed to get the “wet weight.” The material is then first washed 3× in a Tris buffer supplemented with calcium to remove possible remnants of blood still present. Subsequently SAP is extracted from this solution by incubation for 24 h with a Tris buffer supplemented with EDTA and the SAP concentration can be measured in this extract by ELISA [107].
The washed fat tissue is then extracted in a solution of 6 M guanidine hydrochloride and 0.1 M Tris–HCl, pH 8.0, mixed thoroughly, and shaken overnight. The suspension is centrifuged at 10,000×g for 10 min and the supernatant fat tissue extract collected. Microtiter plates are coated with the IgG fraction of the SAA-reactive mouse monoclonal capture antibody Reu.86.5 (Hycult Biotechnology, Uden, The Netherlands). The plates are washed, followed by incubation of the samples. The plates are washed again, followed by incubation with the IgG fraction of the SAA1-reactive mouse monoclonal detection antibody Reu.86.1 (Hycult Biotechnology) coupled to horseradish peroxidase. After washing, the plates are incubated with the chromogen 3′3′5′5′tetramethylbenzidin (TMB, Carl Roth, Karlsruhe, Germany) dissolved in acetate buffer until the reaction is stopped by adding H2SO4. The absorption at 450–575 nm is read in a Versamax microplate reader and amyloid A protein concentrations are calculated by SOFTmax® PRO software (Molecular Devices, Sunnyvale, USA) according to a standard curve of purified SAA. The intra-assay and interassay coefficients of variation are both less than 10 % and the lower limit of detection of the amyloid A protein in fat extract is 1.6 ng/ml extraction fluid. Amyloid A protein concentration reference range of patients without AA amyloidosis is <11.6 ng/mg fat tissue [10, 61]. Recently Hycult has introduced a commercial SAA ELISA kit [108].
In a similar way, concentrations of other important amyloid proteins such as TTR and immunoglobulin light chains kappa and lambda can be measured using ELISA and nephelometry, respectively [64, 65]. Table 16.2 shows the cutoff values that were found in all four assays for the main amyloid types. However, after using the assays for a couple of years the new data have been analyzed to adapt the cutoff values for optimum prediction in daily practice (see Fig. 16.8). PPVs and NPVs have been based on 1886 routine fat tissue samples for AA, 742 samples for ATTR and 596 samples for AL-lambda and kappa immunochemical typing. Finally, 194 routine fat tissue samples have been used to test the assay. No amyloid was found in 34 samples and the remaining 160 amyloid-containing samples were analyzed for all four types. Typing was successful in 58 of 59 CR4+ samples (98 %), 39 of 45 CR3+ samples (87 %), 5 of 25 CR2+ samples (20 %) and 4 of 32 CR1+ samples (13 %). Figure 16.8 shows the decision tree currently used in Groningen for immunochemical typing of amyloid found in fat tissue.
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bijzet, J., van Gameren, I.I., Hazenberg, B.P.C. (2015). Fat Tissue Analysis in the Management of Patients with Systemic Amyloidosis. In: Picken, M., Herrera, G., Dogan, A. (eds) Amyloid and Related Disorders. Current Clinical Pathology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-19294-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-19294-9_16
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-19293-2
Online ISBN: 978-3-319-19294-9
eBook Packages: MedicineMedicine (R0)